Moderate patient-prosthesis mismatch predicts cardiac events and advanced functional class in young and middle-aged

Daniel Hernandez-Vaquero1, Jose M Garcia, Rocio Diaz

  • 1Department of Cardiac Surgery, Central Universitary Hospital of Asturias, Oviedo, Spain.

Journal of Cardiac Surgery
|December 17, 2013
PubMed
Abstract

Insights

Patient-prosthesis mismatch (PPM) after aortic valve replacement (AVR) in younger patients significantly increases cardiac events and worsens functional class. However, PPM does not appear to impact overall mortality in this group.

Area of Science:

  • Cardiovascular Surgery
  • Prosthetic Valve Performance
  • Clinical Outcomes Research

Background:

  • Patient-prosthesis mismatch (PPM) after aortic valve replacement (AVR) is a concern, but its impact on younger and middle-aged patients is not well understood.
  • This study investigates the mid-term clinical significance of PPM in patients under 70 undergoing isolated AVR.

Purpose of the Study:

  • To evaluate the mid-term impact of PPM on overall mortality, quality of life, and cardiac events in patients younger than 70 undergoing AVR.
  • To determine if PPM is an independent predictor of adverse outcomes in this specific demographic.

Main Methods:

  • Analysis of 293 patients younger than 70 who underwent isolated AVR between 2005 and 2011.
  • PPM defined as indexed effective orifice area ≤ 0.85 cm(2)/m(2).
  • Propensity score-stratified analysis to assess the impact of PPM on mortality, cardiac events, and New York Heart Association functional class.

Main Results:

  • 81 patients (27.61%) experienced some degree of PPM.
  • PPM did not significantly affect mid-term overall mortality (HR=1.45; p=0.36).
  • PPM was associated with a significant increase in cardiac events (HR=11.52; p<0.001) and a worse functional class (RR=7.55; p<0.001).

Conclusions:

  • Moderate PPM is a strong, independent predictor of cardiac events and advanced functional class in younger and middle-aged AVR patients with severe aortic stenosis.
  • PPM may not influence overall mortality in this patient population.
  • These findings highlight the importance of considering PPM in AVR selection for younger patients.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
422
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460